on Skin Tech Pharma Group
Skin Tech Pharma Group's RRS® HA Long Lasting Recognized at AMWC 2026
Skin Tech Pharma Group has received the Best Injectable in Skin Revitalization award at the AMWC Aesthetic Medicine Awards 2026 for its RRS® HA LONG LASTING product. Since its 2021 launch, this injectable has marked a significant advancement in the Skin Builder category, with over a million treatments worldwide. The award highlights its role in promoting regenerative aesthetic medicine and meeting the growing demand for natural outcomes in skin health.
RRS® HA Long Lasting is neither a skin booster nor a dermal filler, but a combination of both, featuring cross-linked hyaluronic acid and 15 amino acids. This results in immediate, natural-looking effects and ongoing improvements in skin quality. CEO Márcio Rodrigues views the award as a validation of the company's strategy focusing on scientific rigor and innovation. The product is designed to enhance skin aesthetics while maintaining high safety standards.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Skin Tech Pharma Group news